Picture of Biosynex SA logo

ALBIO Biosynex SA Income Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall Cap

Annual income statement for Biosynex SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
FAS
FAS
FAS
FAS
FAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue30.531.234.2154383
Cost of Revenue
Gross Profit15.316.219.569.3206
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses30.330.733.3109243
Operating Profit0.2520.5180.96544.7140
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes0.10.3710.944.4140
Provision for Income Taxes
Net Income After Taxes0.3150.5431.1232.2107
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income0.3150.5431.1231.4104
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income0.3150.5431.1227.9111
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.0740.0260.1343.110.1
Dividends per Share

Or unlock with your email

Or unlock with your email